Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders in the world, affecting between 10% and 15% of the global population with symptoms that include recurrent abdominal pain, distension, alteration of bowel habits (diarrhea, constipation, or alternation), and significant impact on quality of life. Despite the high prevalence, the conventional therapeutic arsenal is limited: dietary fiber, prokinetic agents, antispasmodics, and antidepressants have partial efficacy and variable tolerability profiles. A meta-analysis published in PLOS ONE in February 2025 offers the most focused analysis available on the specific impact of acupuncture on the quality of life of IBS patients.
The study pooled 14 randomized clinical trials with 2,038 patients and focused on two central outcomes: quality of life (QoL), measured by validated instruments such as the IBS-QoL, and symptom severity, measured by the IBS Symptom Severity Score (IBS-SSS). The differential of this meta-analysis was the subgroup analysis by protocol parameters — needle retention time, weekly frequency, and total treatment duration — making it possible to identify the optimal combination of prescription variables to maximize clinical results.
STUDY DATA
The optimal protocol identified by the meta-analysis
Subgroup analysis by protocol parameters revealed that the effect of acupuncture on quality of life in IBS is significantly influenced by how the treatment is administered. The protocol with the greatest effect combined: retention time of up to 30 minutes per session (longer retention added no benefit), up to 5 sessions per week, and total duration of 4 weeks. This finding has direct practical implication: it is possible to structure a 4-week protocol of moderate intensity (20–25 total sessions) that maximizes improvement of quality of life and symptoms, without requiring prolonged treatment over months.
The reduction of −46.58 points on the IBS-SSS is clinically relevant: the scale ranges from 0 to 500, and a reduction of ≥50 points is generally considered the threshold of clinically significant improvement. The mean reduction observed approaches this threshold, indicating real benefit perceptible by the patient. The improvement in quality of life (MD=6.62 on the IBS-QoL) represents a clinically important difference for the patients' daily experience.
Acupuncture versus conventional treatment of IBS
The RCTs included in the meta-analysis compared acupuncture versus conventional drug treatment ( antispasmodics, low-dose antidepressants, prokinetic agents) and versus waiting list or sham. In both comparisons, acupuncture was superior or equivalent, with a generally favorable safety profile in the included studies (predominantly mild and local adverse events; rare systemic events such as syncope, bleeding, or pneumothorax remain possible). For the quality-of-life subscale, the benefit of acupuncture was consistently superior to conventional drug treatment in the studies that made this direct comparison.
Frequently asked questions
Yes, but with different protocols. This meta-analysis did not stratify by IBS subtype, but individual studies show that acupuncture is effective in both — with technique and point adjustment. For IBS-D, tonification of ST-36, SP-6, and CV-12 with reinforcement of digestive function is prioritized. For IBS-C, electroacupuncture at ST-25 and ST-36 has documented prokinetic effect. The medical acupuncturist assesses the predominant pattern to personalize the protocol.
Acupuncture has demonstrated efficacy as an alternative or complement to conventional treatment. For patients with intolerance, side effects, or unsatisfactory response to medications (antispasmodics, low-dose antidepressants), acupuncture is a first- or second-line option with solid evidence. The decision to reduce or replace medications should be made together with the gastroenterologist responsible for the case.
This meta-analysis identified that the optimal protocol is 4 weeks with up to 5 weekly sessions. In clinical practice, IBS patients frequently report perceptible improvement in acute symptoms (distension, cramping) as early as the first 3–4 sessions. Improvement of quality of life and the global symptom pattern tends to be progressive over the 4 weeks. For maintenance, biweekly or monthly sessions after the initial cycle are recommended.
Founded in 1989 by physicians trained at the University of São Paulo (USP) and specialized in China, CEIMEC is a Brazilian national reference in the teaching and practice of medical acupuncture. With more than 3,000 physicians trained over 35 years, it collaborates with HC-FMUSP and is recognized by the Brazilian Medical College of Acupuncture (CMBA/AMB).